Abstract
Thiazolidinedione, an important heterocyclic ring system, is a pharmacophore and a privileged scaffold in medicinal chemistry. Researchers have shown its potential application as a backbone for inhibitors, as it is involved in anticancer development strategies, cancer progression and metastasis. In this paper, the anticancer activities of thiazolidinedione derivatives were reviewed for the first time with respect to different substituents and their positions. This work may imitate a stirring wheel to guide further advanced development of new anticancer molecules with high efficacy.
Keywords: Thiazolidinedione, Anticancer, Structure-activity relationship, 3D-QSAR, Inhibitors, Molecular Docking.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Thiazolidinedione: A Privileged Scaffold for the Development of Anticancer Agents
Volume: 21 Issue: 28
Author(s): Juan Sun, Yue-Hu Chen, Han-Yu Liu, Emmerson Hondo, Yang Zhou*Yuan-Feng Wu*
Affiliation:
- Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315300,China
- School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou 310023,China
Keywords: Thiazolidinedione, Anticancer, Structure-activity relationship, 3D-QSAR, Inhibitors, Molecular Docking.
Abstract: Thiazolidinedione, an important heterocyclic ring system, is a pharmacophore and a privileged scaffold in medicinal chemistry. Researchers have shown its potential application as a backbone for inhibitors, as it is involved in anticancer development strategies, cancer progression and metastasis. In this paper, the anticancer activities of thiazolidinedione derivatives were reviewed for the first time with respect to different substituents and their positions. This work may imitate a stirring wheel to guide further advanced development of new anticancer molecules with high efficacy.
Export Options
About this article
Cite this article as:
Sun Juan , Chen Yue-Hu , Liu Han-Yu , Hondo Emmerson , Zhou Yang *, Wu Yuan-Feng *, Thiazolidinedione: A Privileged Scaffold for the Development of Anticancer Agents, Current Topics in Medicinal Chemistry 2021; 21 (28) . https://dx.doi.org/10.2174/1568026621666210521143550
DOI https://dx.doi.org/10.2174/1568026621666210521143550 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From the Design to the Clinical Application of Thromboxane Modulators
Current Pharmaceutical Design Protein Kinase C Isoforms - Implications to Thrombosis
Current Signal Transduction Therapy Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Current Topics in Medicinal Chemistry Triazole and Oxadiazole Containing Natural Products: A Review
The Natural Products Journal Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets
Current Signal Transduction Therapy Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry Connecting Parkinsons Disease and Drug Addiction: Common Players Reveal Unexpected Disease Connections and Novel Therapeutic Approaches
Current Pharmaceutical Design Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Current Pharmaceutical Design Expression of P-gp in Glioblastoma: What we can Learn from Brain Development
Current Pharmaceutical Design Dendritic Cell Immunotherapy for Malignant Gliomas
Reviews on Recent Clinical Trials Clinical Trials with Oncolytic Adenovirus in China
Current Cancer Drug Targets Gene Therapy Targeting in the Central Nervous System
Current Gene Therapy Melatonin Receptor as a Drug Target for Neuroprotection
Current Molecular Pharmacology An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry Can we Target the Chemokine Network for Cancer Therapeutics?
Current Cancer Drug Targets